Search

everythinglearnresearchcommunity

for

Search:↓

Gender and social factors, not just biology, affect COVID-19 death rates.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Frankincense may help treat COVID-19, but more research is needed.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Interest in long-COVID symptoms in Japan increased with COVID-19 case peaks, especially for hair loss, cough, smell/taste issues, and headache.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Lifestyle changes, exercise, and antioxidants can help manage polycystic ovary syndrome.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Nearly half of the patients had Long COVID, leading to health and work issues, especially in high-risk groups.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Women, younger age, and low BMI increase the risk of long COVID symptoms.

Long COVID can cause anemia and iron issues, leading to fatigue and slow recovery, especially in men and severe cases.

Long-COVID has diverse, long-term health impacts, especially in young people.

PCOS is linked to gut bacteria changes, suggesting gut-focused treatments might help.

Reinfection patients had more physical complications, while initial infection patients had more mental health issues.